Results 131 to 140 of about 145,320 (184)
Introduction 10% of membranous nephropathy (MN) cases are linked to solid organ tumors, most commonly in Caucasians. Positive anti phospholipase-A2-receptor (PLA2R) autoantibodies are found in 75% of patients with primary MN but are rare in secondary MN ...
Mondreti, Kalyana +3 more
core
Research Advances in Rituximab-Resistant Membranous Nephropathy. [PDF]
Li K, Liu W, Wu D, Su Z, Wan Q.
europepmc +1 more source
Evolution of idiopathic membranous nephropathy to class v lupus nephritis: a case report and literature review. [PDF]
Shen B, Peng C, Xiao W.
europepmc +1 more source
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen. [PDF]
Guo P +7 more
europepmc +1 more source
PLA2R-positive primary membranous nephropathy in an adolescent with type 1 diabetes mellitus and autoimmune hypothyroidism: a case report. [PDF]
Madhuri PS, Venkatachari M.
europepmc +1 more source
Obinutuzumab versus rituximab in refractory membranous nephropathy: a single-center retrospective cohort study. [PDF]
Lei W, Lai HP, Lv Y, Jin L, Xin J.
europepmc +1 more source
Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India. [PDF]
Wani MA +7 more
europepmc +1 more source
Semaphorin 3B-Membranous Nephropathy in Adults. [PDF]
Arevalo Salazar D +4 more
europepmc +1 more source

